156 related articles for article (PubMed ID: 12016452)
1. Multicenter Brazilian study of oral Candida species isolated from AIDS patients.
Sant'Ana Pde L; Milan EP; Martinez R; Queiroz-Telles F; Ferreira MS; Alcântara AP; Carvalho MT; Colombo AL
Mem Inst Oswaldo Cruz; 2002 Mar; 97(2):253-7. PubMed ID: 12016452
[TBL] [Abstract][Full Text] [Related]
2. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Metzger S; Hofmann H
Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A
Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740
[TBL] [Abstract][Full Text] [Related]
4. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
[TBL] [Abstract][Full Text] [Related]
5. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
7. Candida dubliniensis identification in Brazilian yeast stock collection.
Mariano Pde L; Milan EP; da Matta DA; Colombo AL
Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):533-8. PubMed ID: 12937769
[TBL] [Abstract][Full Text] [Related]
8. Oral Candida isolates among HIV-infected subjects in Nigeria.
Nweze EI; Ogbonnaya UL
J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
[TBL] [Abstract][Full Text] [Related]
9. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
10. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
12. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
13. Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia.
Mulu A; Kassu A; Anagaw B; Moges B; Gelaw A; Alemayehu M; Belyhun Y; Biadglegne F; Hurissa Z; Moges F; Isogai E
BMC Infect Dis; 2013 Feb; 13():82. PubMed ID: 23398783
[TBL] [Abstract][Full Text] [Related]
14. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
[TBL] [Abstract][Full Text] [Related]
15. Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
Milan EP; Burattini MN; Kallás EG; Fischmann O; Costa PR; Colombo AL
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):211-6. PubMed ID: 9884838
[TBL] [Abstract][Full Text] [Related]
16. Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study.
Goulart LS; Souza WWR; Vieira CA; Lima JS; Olinda RA; Araújo C
Einstein (Sao Paulo); 2018 Aug; 16(3):eAO4224. PubMed ID: 30088546
[TBL] [Abstract][Full Text] [Related]
17. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
[TBL] [Abstract][Full Text] [Related]
18. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
19. Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia.
Castro LÁ; Álvarez MI; Martínez E
Mycopathologia; 2013 Feb; 175(1-2):91-8. PubMed ID: 23086383
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
